顺二氨二氯铂（NSC - 119875）的临床试验。 - Suppr

Suppr

超能文献

Clinical trials of cis-diamminedichloroplatinum (NSC-119875).

作者信息

Lippman A J, Helson C, Helson L, Krakoff I H

出版信息

Cancer Chemother Rep. 1973 Apr;57(2):191-200.

PMID:4126381

Abstract

摘要

相似文献

Clinical trials of cis-diamminedichloroplatinum (NSC-119875).顺二氨二氯铂（NSC - 119875）的临床试验。

Cancer Chemother Rep. 1973 Apr;57(2):191-200.

Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study.顺二氨二氯铂（NSC - 119875）毒性作用的临床评估——I期临床研究

Cancer Chemother Rep. 1973 Nov-Dec;57(4):465-71.

Combination chemothereapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck.

Oncology. 1975;32(5-6):202-7. doi: 10.1159/000225069.

Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man.顺二氨二氯铂（NSC - 119875）对人体听力功能的影响。

Cancer Chemother Rep. 1974 Nov-Dec;58(6):871-5.

Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.

Cancer Chemother Rep. 1973 Sep-Oct;57(3):357-9.

Cis-diamminedichloroplatinum (NSC-119875): a phase I study.

Cancer Chemother Rep. 1973 Nov-Dec;57(4):459-63.

Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP).顺二氯二氨铂（II）（NSC 119875，CACP）的初步临床经验

Cancer. 1972 Dec;30(6):1451-6. doi: 10.1002/1097-0142(197212)30:6<1451::aid-cncr2820300606>3.0.co;2-q.

[Cis-diamminedichloroplatinum(II) chemotherapy in advanced pancreatic carcinoma].

Gan To Kagaku Ryoho. 1987 Nov;14(11):3101-4.

Cis-diamminedichloroplatinum (II). A new anticancer drug.顺二氯二氨合铂（II）。一种新型抗癌药物。

Ann Intern Med. 1977 Jun;86(6):803-12. doi: 10.7326/0003-4819-86-6-803.

Cisplatin as adjunctive treatment for invasive bladder carcinoma: tolerance and toxicities.顺铂作为浸润性膀胱癌的辅助治疗：耐受性和毒性。

Urology. 1984 Apr;23(4 Suppl):110-7. doi: 10.1016/s0090-4295(84)80080-1.

引用本文的文献

Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury.雷帕霉素全氟碳纳米颗粒减轻顺铂诱导的急性肾损伤。

Int J Mol Sci. 2023 Mar 23;24(7):6086. doi: 10.3390/ijms24076086.

Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury.雷帕霉素全氟碳纳米颗粒预防顺铂诱导的肾损伤的安全性概况

Nanomaterials (Basel). 2022 Jan 21;12(3):336. doi: 10.3390/nano12030336.

Protective Effect of Mannitol on Cisplatin-Induced Nephrotoxicity: A Systematic Review and Meta-Analysis.甘露醇对顺铂诱导的肾毒性的保护作用：一项系统评价和荟萃分析。

Front Oncol. 2021 Dec 16;11:804685. doi: 10.3389/fonc.2021.804685. eCollection 2021.

Circadian vulnerability of cisplatin-induced ototoxicity in the cochlea.耳蜗中顺铂诱导耳毒性的昼夜节律易损性。

FASEB J. 2020 Oct;34(10):13978-13992. doi: 10.1096/fj.202001236R. Epub 2020 Aug 24.

Ameliorates Cisplatin-Induced Nephrotoxicity.改善顺铂诱导的肾毒性。

Biomed Res Int. 2019 Dec 6;2019:3960908. doi: 10.1155/2019/3960908. eCollection 2019.

Prevention of Cisplatin-Induced Acute Kidney Injury: A Systematic Review and Meta-Analysis.顺铂所致急性肾损伤的预防：系统评价和荟萃分析。

Drugs. 2019 Sep;79(14):1567-1582. doi: 10.1007/s40265-019-01182-1.

Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review.免疫检查点抑制剂相关肾毒性的诊断与治疗：实例分析与文献复习。

Oncologist. 2019 Jun;24(6):735-742. doi: 10.1634/theoncologist.2018-0764. Epub 2019 Mar 22.

The genetic vulnerability to cisplatin ototoxicity: a systematic review.顺铂耳毒性的遗传易感性：系统评价。

Sci Rep. 2019 Mar 5;9(1):3455. doi: 10.1038/s41598-019-40138-z.

An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity.顺铂诱导耳毒性的优化、临床相关的小鼠模型。

Hear Res. 2019 Apr;375:66-74. doi: 10.1016/j.heares.2019.02.006. Epub 2019 Feb 22.

A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.预防顺铂诱导的肾毒性策略的系统评价

Oncologist. 2017 May;22(5):609-619. doi: 10.1634/theoncologist.2016-0319. Epub 2017 Apr 24.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验